Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

52.9700 USD 0.6200 1.16%

As of 20:04:06 ET on 01/30/2015.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 53.5100 High - Low: 54.2348 - 52.8431 Primary Exchange: NYSE Arca
Volume: 48,875 52-Week Range: 36.8800 - 54.4600 Beta vs DZOTR: 1.0021

ETF Chart for PBE

No chart data available.
  • PBE:US 52.9700
  • 1D
  • 1M
  • 1Y
53.5900
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD / MICHAEL JEANETTE
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2015-01-30) 52.8564
Assets (M) (on 2015-01-30) 496.8496
Shares out (M) 9.40
Market Cap (M) 497.92
% Premium 0.21
Average 52-Week % Premium 0.0075
Fund Leveraged N

Dividends for PBE

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.0429
Dividend Yield (ttm) 0.52%

Performance for PBE

1-Month +5.52% 1-Year +27.03%
3-Month +6.17% 3-Year +34.53%
Year To Date +5.52% 5-Year +25.75%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 01/30/2015
Name Position Value % of Total
Biogen Idec Inc 77,351 30,101,915 6.057%
BioMarin Pharmaceutical Inc 265,288 25,775,382 5.186%
Gilead Sciences Inc 237,257 24,871,651 5.004%
Illumina Inc 124,686 24,337,460 4.897%
Sigma-Aldrich Corp 174,245 23,962,172 4.821%
Regeneron Pharmaceuticals Inc 57,198 23,832,119 4.795%
Alexion Pharmaceuticals Inc 122,119 22,377,086 4.502%
Amgen Inc 143,983 21,922,852 4.411%
Isis Pharmaceuticals Inc 250,678 17,173,950 3.455%
Insys Therapeutics Inc 335,212 16,016,429 3.223%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil